Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sangamo Therapeutics Inc (NASDAQ:SGMO)

7.25
Delayed Data
As of May 26
 -0.55 / -7.05%
Today’s Change
2.65
Today|||52-Week Range
8.60
+137.70%
Year-to-Date

Today’s Trading

Previous close7.80
Today’s open7.80
Day’s range7.25 - 7.90
Volume1,247,466
Average volume (3 months)1,039,224
Market cap$521.6M
Dividend yield--
Data as of 3:59pm ET, 05/26/2017

Growth & Valuation

Earnings growth (last year)-75.86%
Earnings growth (this year)-10.59%
Earnings growth (next 5 years)+24.50%
Revenue growth (last year)-50.96%
P/E ratioNM
Price/Sales11.10
Price/Book3.77

Competitors

 Today’s
change
Today’s
% change
AUPHAurinia Pharmaceutic...-0.23-3.49%
ANABAnaptysBio Inc-1.00-3.75%
ANIPANI Pharmaceuticals ...-1.43-3.02%
ADAPAdaptimmune Therapeu...+0.02+0.38%
Data as of 3:59pm ET, 05/26/2017

Financials

Next reporting dateJuly 26, 2017
EPS forecast (this quarter)-$0.27
Annual revenue (last year)$19.4M
Annual profit (last year)-$71.7M
Net profit margin-369.58%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Alexander Macrae
Chief Financial Officer &
Senior Vice President
Kathy Yi
Corporate headquarters
Richmond, California

Forecasts